Loading…
Attending this event?
Back To Schedule
Wednesday, June 19 • 1:15pm - 2:15pm
#352: Applying Machine Learning and Artificial intelligence for Predicting Product Profile Approvability (PoPPA)

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-24-655-L04-P; CME 1.00; RN 1.00

This will be an interactive panel discussion with experts sharing examples how AI/ML can be used to create solutions for better regulatory decision-making and predicting regulatory success. Risks and benefits of using this approach will be discussed.

Panelists will include world-renowned experts on drug development, drug regulations, decision science and data analytics.

Learning Objectives

Evaluate how AI/ML can be used to help with regulatory decision making; Analyze scenarios using case studies by world’s leading expert on drug development, cloud computing, and predicting regulatory success; Compare risks and benefits for using this evolving technology.

Chair

Romi Singh, PhD

Speaker

Panelist
Kilian Weiss

Panelist
Subha Madhavan, PhD, FACMI

Panelist
Lily Li, JD


Speakers
avatar for Romi Singh

Romi Singh

Founder & Principal Advisor, GRA Advisors, United States
Dr. Romi Singh is a highly accomplished thought leader in global drug registration, multiregional clinical trials, and the application of AI/ML in regulatory sciences. Dr. Singh was appointed Professor of Practice at Northeastern University after a successful career at leading biopharma... Read More →
LL

Lily Li

Founder and President, Metaverse Law, United States
Lily Li is the founder and president of Metaverse Law, a firm that focuses exclusively on privacy, AI, and cybersecurity law. She advises mid-sized, public, and multinational clients on a broad range of AI and data protection matters, such as the CCPA, GDPR, NIST AI Framework, Biden... Read More →
avatar for Subha Madhavan

Subha Madhavan

Vice President and Head of AI/ML, Global Biometrics and Data Management, Pfizer Inc, United States
Subha Madhavan heads up AI/ML, Quantitative and Digital Sciences within Global Product Development at Pfizer. Prior to joining Pfizer, she was Head of Data Science and AI within Oncology R&D Strategy at AstraZeneca Pharmaceuticals. She has initiated and successfully directed several... Read More →
KW

Kilian Weiss

General Manager, Veeva Link and OpenData, Veeva, Germany
As general manager of Veeva Link and OpenData, Kilian is responsible for the strategic direction, growth, and customer success of Veeva’s global Link and OpenData Platform. Before joining Veeva, Kilian founded Mederi, a leading provider of global KOL data and services for life sciences... Read More →

Wednesday June 19, 2024 1:15pm - 2:15pm PDT
Room 6F San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  09: Regulatory, Forum